BLAKE HENCHCLIFFE: Open Payments
NPI 1982191409 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 16 payments from 9 companies in 2025. Trend: 2023 $2,875 · 2024 $733 · 2025 $690
Food & beverage: $579Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $206 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| ABBVIE INC. | 4 | $86 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Lundbeck LLC | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $20 |
Products named: Auvelity, INGREZZA, VRAYLAR, REXULTI, COBENFY, CAPLYTA, ARISTADA.
Industry payments across TX — which companies pay providers there.
